Molecular Pharmaceutics
[ASAP] A Colon-Targeted Prodrug of Riluzole Improves Therapeutic Effectiveness and Safety upon Drug Repositioning of Riluzole to an Anti-Colitic Drug
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00255
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00255
Journal of the American Chemical SocietyDOI: 10.1021/jacs.2c07422
Journal of the American Chemical SocietyDOI: 10.1021/jacs.2c07489
Journal of the American Chemical SocietyDOI: 10.1021/jacs.2c06835
Journal of the American Chemical SocietyDOI: 10.1021/jacs.2c04064
Journal of the American Chemical SocietyDOI: 10.1021/jacs.2c04984
Journal of the American Chemical SocietyDOI: 10.1021/jacs.2c04418
Journal of the American Chemical SocietyDOI: 10.1021/jacs.2c03511
Journal of the American Chemical SocietyDOI: 10.1021/jacs.2c07023
Journal of the American Chemical SocietyDOI: 10.1021/jacs.2c08200